NCT00111228View on ClinicalTrials.gov

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

NACompletedINTERVENTIONAL

Enrollment

162

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Diabetes Mellitus

Interventions

DEVICE

Guardian RT

DEVICE

SMBG only

Trial Locations (8)

20132

Universita Vita-Salute OspedaleS.Raffaele, Milan

49202

Schneider Children Centre, Petah Tikva

75019

CH Robert Debre, Paris

91106

Hôpital Sud Francilien, Corbeil Esssonnes

D-13353

Klinik für Allgemeine Charité, CVK, Berlin

SI-1525

University Children's Hospital, Ljubljana

SE-141 86

Huddinge University Hospital, Huddinge

Dorset BH7 7DW

Royal Bournemouth Hospital, Bournemouth

All Listed Sponsors

lead

Medtronic Diabetes

INDUSTRY

NCT00111228 - The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT | Biotech Hunter | Biotech Hunter